News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Flugen, Inc.-Arecor Partnership Enhances Promise of Universal Flu Vaccine Through Funding Award From the UK’s Innovation Agency, the Technology Strategy Board


7/30/2013 6:44:21 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MADISON, Wis.--(BUSINESS WIRE)--Arecor Ltd of Cambridge, England received the funding to pursue a research project applying Arecor’s innovative Arestat™ formulation technology to a promising flu vaccine, REDEE FLU™, developed by FluGen, Inc., of Madison, WI. The UK’s innovation agency, the Technology Strategy Board, has awarded Arecor a Proof of Concept award through its Smart programme, to engage in research and development in the strategically important area of developing a stable formulation for REDEE FLU™.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com

comments powered by Disqus
   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES